期刊
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6
卷 6, 期 -, 页码 95-119出版社
ANNUAL REVIEWS
DOI: 10.1146/annurev.pathol.3.121806.154244
关键词
genetically engineered mice; gene targeting; oncogene; tumor-suppressor gene; cancer-gene discovery; oncogenomics
类别
资金
- NATIONAL CANCER INSTITUTE [R01CA103924] Funding Source: NIH RePORTER
- NCI NIH HHS [R01 CA103924] Funding Source: Medline
Genetically engineered mouse models have significantly contributed to our understanding of cancer biology. They have proven to be useful in validating gene functions, identifying novel cancer genes and tumor biomarkers, gaining insight into the molecular and cellular mechanisms underlying tumor initiation and multistage processes of tumorigenesis, and providing better clinical models in which to test novel therapeutic strategies. However, mice still have significant limitations in modeling human cancer, including species-specific differences and inaccurate recapitulation of de novo human tumor development. Future challenges in mouse modeling include the generation of clinically relevant mouse models that recapitulate the molecular, cellular, and genomic events of human cancers and clinical response as well as the development of technologies that allow for efficient in vivo imaging and high-throughput screening in mice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据